Loading...
 
Toggle Health Problems and D

Diabetes and Vitamin D references (PDF behind paywall) – Jan 2017

Vitamin D and diabetes mellitus: Causal or casual association?

Reviews in Endocrine and Metabolic Disorders, pp 1–15, First Online: 07 January 2017
DOI: 10.1007/s11154-016-9403-y
M. GrammatikiE. RaptiS. KarrasR. A. AjjanKalliopi Kotsa

See also Vitamin D Life

Diabetes category starts with the following

454 items In Diabetes category

see also Overview Diabetes and vitamin D  Overview Metabolic Syndrome and vitamin D

Autoimmune category listing has 164 items along with related searches

T1 diabetes OR type1 diabetes in title 107 as of April 2018
prediabetes OR prediabetic 336 items as of Jan 2018
Search Vitamin D Life for Peripheral Neuropathy 238 items April 2018
Overview Diabetes and vitamin D contains the following summary

  • Diabetes is 5X more frequent far from the equator
  • Children getting 2,000 IU of vitamin D are 8X less likely to get Type 1 diabetes
  • Obese people get less sun / Vitamin D - and also vitamin D gets lost in fat
  • Sedentary people get less sun / Vitamin D
  • Worldwide Diabetes increase has been concurrent with vitamin D decrease and air conditioning
  • Elderly get 4X less vitamin D from the same amount of sun
        Elderly also spend less time outdoors and have more clothes on
  • All items in category Diabetes and Vitamin D 454 items: both Type 1 and Type 2

Vitamin D appears to both prevent and treat diabetes

  • Appears that >2,000 IU will Prevent
  • Appears that >4,000 IU will Treat , but not cure
  • Appears that Calcium and Magnesium are needed for both Prevention and Treatment
    • which are just some of the vitamin D cofactors

Number of articles in both categories of Diabetes and:

  • Dark Skin 22;   Intervention 49;   Meta-analysis 28;   Obesity 26;  Pregnancy 39;   T1 (child) 34;  Omega-3 10;  Vitamin D Receptor 18;  Genetics 10;  Magnesium 18    Click here to see details

Publisher wants $40 for the PDF
PDF was not at Sci=Hub as of June 2018
DeepDyve has a copy which can be read, not saved

The incidence of both type 2 and type 1 diabetes mellitus has been increasing worldwide. Vitamin D deficiency, or the awareness of its prevalence, has also been increasing. Vitamin D may have a role in the pathogenic mechanisms predisposing to type 2 diabetes by modulating insulin resistance and/or pancreatic ß-cell function. Vitamin D status or elements involved in its activation or transport may also be involved in the development of type 1 diabetes mellitus through immunomodulatory role . Based on these observations a potential association between vitamin D and diabetes has been hypothesized. In this review we discuss up to date evidence linking vitamin D with the development of diabetes. Moreover, the role of vitamin D supplementation in the prevention of both types of diabetes is analysed together with its role in improving glycemic control in diabetic patients. We also address the potential role of vitamin D deficiency in the development of macro- and microvascular complications in diabetes. Finally, we provide recommendation for Vitamin D therapy in diabetes in view of current evidence and highlight areas for potential future research in this area.

References

  • 1 Leahy JL. Pathogenesis of type 2 diabetes mellitus. Arch Med Res. 2005;36(3):197–209 PubMedCrossRefGoogle Scholar
  • 2 Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. Engl J Med. 1995;331:1428–36 Google Scholar
  • 3 Harinarayan CV. Vitamin D, and diabetes mellitus. Hormones. 2014;13(2):163–81 PubMedGoogle Scholar
  • 4 Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Rheum Dis Clin North Am. 2012;38(1):179–206 PubMedCrossRefGoogle Scholar
  • 5 Chuang JC, Cha JY, Garmey JC, Mirmira RG, Repa JJ. Research resource: nuclear hormone receptor expression in the endocrine pancreas. Molecular endocrinology. 2008;22(10):2353–63 PubMedPubMedCentralCrossRefGoogle Scholar
  • 6 Pludowski P, Holick MF, Pilz S, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmunity reviews. 2013;12(10):976–89 PubMedCrossRefGoogle Scholar
  • 7 Fan Y, Futawaka K, Koyama R, et al. Vitamin D3/VDR resists diet-induced obesity by modulating UCP3 expression in muscles. J Biomed Sci. 2016;23(1):56 PubMedPubMedCentralCrossRefGoogle Scholar
  • 8 Zostautiene I, Jorde R, Schirmer H, et al. Genetic Variations in the Vitamin D Receptor Predict Type 2 diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study. PLoS One. 2015;10(12), e0145359 PubMedPubMedCentralCrossRefGoogle Scholar
  • 9 Li L, Wu B, Liu JY, Yang LB. Vitamin D receptor gene polymorphisms and type 2 diabetes: a meta-analysis. Archives Med Res. 2013;44(3):235–41 CrossRefGoogle Scholar
  • 10 Pilz S, Kienreich K, Rutters F, et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Curr Diab Rep. 2013;13(2):261–70 PubMedCrossRefGoogle Scholar
  • 11 Zhukouskaya VV, Eller-Vainicher C, Shepelkevich AP, Dydyshko Y, Cairoli E, Chiodini I. Bone health in type 1 diabetes: focus on evaluation and treatment in clinical practice. J Endocrinol Invest. 2015;38(9):941–50 PubMedCrossRefGoogle Scholar
  • 12 Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Chapter 1: Epidemiology of Type 1 diabetes. Endocrinol Metab Clin North Am. 2010;39(3):481–97 PubMedPubMedCentralCrossRefGoogle Scholar
  • 13 Chagas CE, Borges MC, Martini LA, Rogero MM. Focus on vitamin D, inflammation and type 2 diabetes. Nutrients. 2012;4:52–67 PubMedPubMedCentralCrossRefGoogle Scholar
  • 14 Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006;147(12):5542–8 PubMedCrossRefGoogle Scholar
  • 15 Maestro B, Campion J, Davila N, Calle C. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J. 2000;47:383–91 PubMedCrossRefGoogle Scholar
  • 16 Wright DC, Hucker KA, Holloszy JO, Han DH. Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. diabetes. 2004;53:330–5 PubMedCrossRefGoogle Scholar
  • 17 Draznin B, Sussman K, Kao M, Lewis D, Sherman N. The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J Biol Chem. 1987;262:14385–8 PubMedGoogle Scholar
  • 18 Draznin B. Cytosolic calcium and insulin resistance. Am J Kidney Dis. 1993;21:32–8 PubMedCrossRefGoogle Scholar
  • 19 Reusch JE, Begum N, Sussman KE, Draznin B. Regulation of GLUT-4 phosphorylation by intracellular calcium in adipocytes. Endocrinology. 1991;129:3269–73 PubMedCrossRefGoogle Scholar
  • 20 Dunlop TW, Väisänen S, Frank C, Molnár F, Sinkkonen L, Carl-berg C. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol. 2005;349:248–60 PubMedCrossRefGoogle Scholar
  • 21 Cade C, Norman AW. Rapid normalization/stimulation by 1,25-dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the Vitamin D-deficient rat. Endocrinology. 1987;120:1490–7 PubMedCrossRefGoogle Scholar
  • 22 Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am J Physiol. 1994;267:E356–60 PubMedGoogle Scholar
  • 23 Bland R, Markovic D, Hills CE, et al. Expression of 25- hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol. 2004;89–90:121–5 PubMedCrossRefGoogle Scholar
  • 24 Maestro B, Davila N, Carranza MC, Calle C. Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol. 2003;84:223–30 PubMedCrossRefGoogle Scholar
  • 25 Maestro B, Molero S, Bajo S, Davila N, Calle C. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). Cell Biochem Funct. 2002;20:227–32 PubMedCrossRefGoogle Scholar
  • 26 Bourlon PM, Billaudel B, Faure-Dussert A. Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol. 1999;160:87–95 PubMedCrossRefGoogle Scholar
  • 27 Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. Faseb J. 2003;17:509–51 PubMedGoogle Scholar
  • 28 Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta- analysis. J Clin Endocrinol Metab. 2007;92:2017–29 PubMedPubMedCentralCrossRefGoogle Scholar
  • 29 Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327–34 PubMedCrossRefGoogle Scholar
  • 30 Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. diabetes. 2004;53:693–700 PubMedCrossRefGoogle Scholar
  • 31 Chih-Chien S, Min-Tser L, Kuo-Cheng L, Chia-Chao W. Role of Vitamin D in Insulin Resistance. J Biomed Biotechnol. 2012;2012:634195 Google Scholar
  • 32 Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and insulin resistance. J Clin Endocrinol Metab. 2004;89:447–52 PubMedCrossRefGoogle Scholar
  • 33 Christakos S, Liu Y. Biological actions and mechanism of action of calbindin in the process of apoptosis. J Steroid Biochem Mol Biol. 2004;89-90(1–5):401–4 PubMedCrossRefGoogle Scholar
  • 34 Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science. 1980;209(4458):823–5 PubMedCrossRefGoogle Scholar
  • 35 Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79(5):820–5 PubMedGoogle Scholar
  • 36 Hyppönen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. diabetes. 2008;57(2):298–305 PubMedCrossRefGoogle Scholar
  • 37 Lu L, Yu Z, Pan A, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. diabetes Care. 2009;32(7):1278–83 PubMedPubMedCentralCrossRefGoogle Scholar
  • 38 Scragg R, Sowers M. Bell C; Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. diabetes Care. 2004;27(12):2813–8 PubMedCrossRefGoogle Scholar
  • 39 Reis JP, von Muhlen D, Kritz-Silverstein D, et al. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. diabetes Care. 2007;30:1549–55 PubMedCrossRefGoogle Scholar
  • 40 Afzal S, Bojesen SE, Nordestgaard BG. Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. Clin Chem. 2013;52(2):381–91 CrossRefGoogle Scholar
  • 41 Anderson JL, May HT, Horne BD, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106:963–8 PubMedCrossRefGoogle Scholar
  • 42 Forouhi NG, Ye Z, Rickard AP, et al. Circulating 25- hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia. 2012;55:2173–82 PubMedCrossRefGoogle Scholar
  • 43 Gagnon C, Lu ZX, Magliano DJ, et al. Serum 25- hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian diabetes, Obesity and Lifestyle study). diabetes Care. 2011;34:1133–8 PubMedPubMedCentralCrossRefGoogle Scholar
  • 44 Gonzalez-MoleroI R-MG, Morcillo S, et al. Vitamin D and incidence of diabetes: a prospective cohort study. Clin Nutr. 2012;31:571–3 CrossRefGoogle Scholar
  • 45 Grimnes G, Emaus N, Joakimsen RM, et al. Baseline serum 25-hydroxyvitamin D concentrations in the Tromso Study 1994–95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up. Diabet Med. 2010;27:1107–15 PubMedCrossRefGoogle Scholar
  • 46 Hurskainen AR, Virtanen JK, Tuomainen TP, Nurmi T, Voutilainen S. Association of serum 25-hydroxyvitamin D with type 2 diabetes and markers of insulin resistance in a general older population in Finland. diabetes Metab Res Rev. 2012;28:418–23 PubMedCrossRefGoogle Scholar
  • 47 Husemoen LL, Thuesen BH. Fenger M, Jørgensen T, Glu ¨mer C, Svensson J, et al. Serum 25(OH)D and type 2 diabetes association in a general population. diabetes Care. 2012;35:1695–700 PubMedPubMedCentralCrossRefGoogle Scholar
  • 48 Knekt P, Laaksonen M, Mattila C, et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology. 2008;19:666–71 PubMedCrossRefGoogle Scholar
  • 49 Pilz S, van den Hurk K, Nijpels G, et al. Vitamin D status, incident diabetes and prospective changes in glucose metabolism in older subjects: the Hoorn study. Nutr Metab Cardiovasc Dis. 2012;22:883–9 PubMedCrossRefGoogle Scholar
  • 50 Pittas AG, Sun Q, Manson JE, Dawson-Hughes B, Hu FB. Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. diabetes Care. 2010;33:2021–3 PubMedPubMedCentralCrossRefGoogle Scholar
  • 51 Robinson JG, Manson JE, Larson J, et al. Lack of association between 25(OH)D levels and incident type 2 diabetes in older women. diabetes Care. 2011;34:628–34 PubMedPubMedCentralCrossRefGoogle Scholar
  • 52 Thorand B, Zierer A, Huth C, et al. Effect of serum 25- hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: results from the MONICA/KORA Augsburg study. diabetes Care. 2011;34:2320–2 PubMedPubMedCentralCrossRefGoogle Scholar
  • 53 Deleskog A, Hilding A, Brismar K, Hamsten A, Efendic S, Ostenson CG. Low serum 25- hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance. Diabetologia. 2012;55:1668–78 PubMedCrossRefGoogle Scholar
  • 54 Pittas AG, Harris SS, Stark PC, et al. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. diabetes Care. 2007;30:980–6 PubMedCrossRefGoogle Scholar
  • 55 de Boer IH, Tinker LF, Connelly S, et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women’s Health Initiative. diabetes Care. 2008;31:701–7 PubMedPubMedCentralCrossRefGoogle Scholar
  • 56 Avenell A, Cook JA, MacLennan GS, et al. Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing. 2009;38:606–9 PubMedCrossRefGoogle Scholar
  • 57 Zittermann A, Frisch S, Berthold HK, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr. 2009;89:1321–7 PubMedCrossRefGoogle Scholar
  • 58 von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr. 2010;103:549–55 CrossRefGoogle Scholar
  • 59 Jorde R, Sneve M, Torjesen P, et al. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med. 2010;267:462–72 PubMedCrossRefGoogle Scholar
  • 60 Wood AD, Secombes KR, Thies F, et al. Vitamin D3 Supplementation Has No Effect on Conventional Cardiovascular Risk Factors: A Parallel-Group, Double-Blind, Placebo-Controlled RCT. J Clin Endocrinol Metab. 2012;97:3557–68 PubMedCrossRefGoogle Scholar
  • 61 Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med. 2009;26:19–27 PubMedCrossRefGoogle Scholar
  • 62 Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403 PubMedCrossRefGoogle Scholar
  • 63 Mitri J, Dawson-Hughes B, Hu FB, et al. Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr. 2011;94:486–94 PubMedPubMedCentralCrossRefGoogle Scholar
  • 64 Nazarian S, St Peter JV, Boston RC, et al. Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose. Transl Res. 2011;158:276–81 PubMedPubMedCentralCrossRefGoogle Scholar
  • 65 Jorde R, Sollid ST, Svartberg J, et al. Vitamin D 20,000 IU per Week for Five Years Does Not Prevent Progression From Prediabetes to diabetes. J Clin Endocrinol Metab. 2016;101(4):1647–55 PubMedCrossRefGoogle Scholar
  • 66 Tuomainen TP, Virtanen JK, Voutilainen S, Nurmi T, Mursu J, de Mello VD, et al. Glucose Metabolism Effects of Vitamin D in Prediabetes: The VitDmet Randomized Placebo-Controlled Supplementation Study. J diabetes Res. 2015;2015:672653 PubMedPubMedCentralCrossRefGoogle Scholar
  • 67 Barengolts E, Manickam B, Eisenberg Y, Akbar A, Kukreja S, Ciubotaru I. Effect of high-dose vitamin D repletion on glycemic control in African-American males with prediabetes and hypovitaminosis D. Endocr Pract. 2015;21(6):604–12 PubMedPubMedCentralCrossRefGoogle Scholar
  • 68 Oosterwerff MM, Eekhoff EM, Van Schoor NM, et al. Effect of moderate-dose vitamin D supplementation on insulin sensitivity in vitamin D–deficient non-Western immigrants in the Netherlands: a randomized placebo-controlled trial. Am J Clin Nutr. 2014;100(1):152–60 PubMedCrossRefGoogle Scholar
  • 69 Davidson MB, Duran P, Lee ML, Friedman TC. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. diabetes Care. 2013;36(2):260–6 PubMedPubMedCentralCrossRefGoogle Scholar
  • 70 Poolspup N, Suksomboon N, Plordplong N. Effect of vitamin D supplementation on insulin resistance and glycaemic control in prediabetes: a systematic review and meta-analysis. Diabet Med. 2016;33(3):290–9 CrossRefGoogle Scholar
  • 71 Seida JC, Mitri J, Colmers IN, et al. Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014;99(10):3551–60 PubMedPubMedCentralCrossRefGoogle Scholar
  • 72 Sorkin JD, Vasaitis TS, Streeten E, Ryan AS, Goldberg AP. Evidence for threshold effects of 25-hydroxyvitamin D on glucose tolerance and insulin resistance in black and white obese postmenopausal women. J Nutr. 2014;144:734–42 PubMedPubMedCentralCrossRefGoogle Scholar
  • 73 Pittas AG, Dawson-Hughes B, Sheehan PR, et al. D2d Research Group. Rationale and design of the Vitamin D and Type 2 diabetes (D2d) study: a diabetes prevention trial. diabetes Care. 2014;37(12):3227–34 PubMedPubMedCentralCrossRefGoogle Scholar
  • 74 Krul-Poel YH, Westra S, ten Boekel E, et al. Effect of Vitamin D Supplementation on Glycemic Control in Patients With Type 2 diabetes (SUNNY Trial): A Randomized Placebo-Controlled Trial. diabetes Care. 2015;38(8):1420–6 PubMedCrossRefGoogle Scholar
  • 75 Hewison M. An update on vitaminDandhuman immunity. Clin Endocrinol. 2012;76:315–25 CrossRefGoogle Scholar
  • 76 Olt S. Relationship between vitamin D and glycemic control in patients with type 2 diabetes mellitus. Int J Clin Exp Med. 2015;8(10):19180–3 PubMedPubMedCentralGoogle Scholar
  • 77 Kostoglou-Athanassiou I, Athanassiou P, Gkountouvas A, Kaldrymides P. Vitamin D and glycemic control in diabetes mellitus type 2. Ther Adv Endocrinol Metab. 2013;4(4):122–8 PubMedPubMedCentralCrossRefGoogle Scholar
  • 78 Orwoll E, Riddle M, Prince M. Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr. 1994;59(5):1083–7 PubMedGoogle Scholar
  • 79 Talaei A, Mohamadi M, Adgi Z. The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabetol Metab Syndr. 2013;5:8 PubMedPubMedCentralCrossRefGoogle Scholar
  • 80 George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med. 2012;29(8):e142–50 PubMedCrossRefGoogle Scholar
  • 81 Krul-Poel YH, Ter Wee M, Lips P, Simsek S. MANAGEMENT OF ENDOCRINE DISEASE: The effect of vitamin D supplementation on glycaemic control in patients with Type 2 diabetes Mellitus: a systematic review and meta-analysis. Eur J Endocrinol. 2016 82 Bellastella G, Maiorino MI, Olita L, et al. Vitamin D deficiency in type 2 diabetic patients with hypogonadism. J Sex Med. 2014;11:536–42 PubMedCrossRefGoogle Scholar
  • 83 Ibrahim MA, Sarhan II, Halawa MR, et al. Study of the effect of vitamin D supplementation on glycemic control in type 2 diabetic prevalent hemodialysis patients. Hemodial Int. 2015;19 Suppl 3:S11–9 PubMedCrossRefGoogle Scholar
  • 84 Perez-Diaz I, Sebastian-Barajas G, Hernandez-Flores ZG, Rivera-Moscoso R, Osorio-Landa HK, Flores-Rebollar A. The impact of vitamin D levels on glycemic control and bone mineral density in postmenopausal women with type 2 diabetes. J Endocrinol Invest. 2015;38(12):1365–72 PubMedCrossRefGoogle Scholar
  • 85 Shaseb E, Tohidi M, Abbasinazari M, et al. The effect of a single dose of vitamin D on glycemic status and C-reactive protein levels in type 2 diabetic patients with ischemic heart disease: a randomized clinical trial. Acta Diabetol. 2016;53(4):575–82 PubMedCrossRefGoogle Scholar
  • 86 Steck AK, Rewers MJ. Genetics of type 1 diabetes. Clin Chem. 2011;57(2):176–85 PubMedPubMedCentralCrossRefGoogle Scholar
  • 87 Ogunkolade BW, Boucher BJ, Prahl JM, et al. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. diabetes. 2002;51(7):2294–300 PubMedCrossRefGoogle Scholar
  • 88 Garcia D, Angel B, Carrasco E, et al. VDR polymorphisms influence the immune response in type 1 diabetic children from Santiago. Chile diabetes Res Clin Pract. 2007;77(1):134–40 PubMedCrossRefGoogle Scholar
  • 89 Pani MA, Knapp M, Donner H, et al. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. diabetes. 2000;49(3):504–7 PubMedCrossRefGoogle Scholar
  • 90 Chang TJ, Lei HH, Yeh JI, et al. Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clin Endocrinol (Oxf). 2000;52(5):575–80 CrossRefGoogle Scholar
  • 91 Lemos MC, Fagulha A, Coutinho E, et al. Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population. Hum Immunol. 2008;69(2):134–8 PubMedCrossRefGoogle Scholar
  • 92 Turpeinen H, Hermann R, Vaara S, et al. Vitamin D receptor polymorphisms: no association with type 1 diabetes in the Finnish population. Eur J Endocrinol. 2003;149(6):591–6 PubMedCrossRefGoogle Scholar
  • 93 Tizaoui K, Kaabachi W, Hamzaoui A, Hamzaoui K. Contribution of VDR polymorphisms to type 1 diabetes susceptibility: Systematic review of case–control studies and meta-analysis. J Steroid Biochem Mol Biol. 2014;143:240–9 PubMedCrossRefGoogle Scholar
  • 94 Ongagna JC, Pinget M, Belcourt A. Vitamin D-binding protein gene polymorphism association with IA-2 autoantibodies in type 1 diabetes. Clin Biochem. 2005;38(5):415–9 PubMedCrossRefGoogle Scholar
  • 95 Ongagna JC, Kaltenbacher MC, Sapin R, Pinget M, Belcourt A. The HLA-DQB alleles and amino acid variants of the vitamin Dbinding protein in diabetic patients in Alsace. Clin Biochem. 2001;34:59–63 PubMedCrossRefGoogle Scholar
  • 96 Thorsen SU, Mortensen HB, Carstensen B, et al. No association between type 1 diabetes and genetic variation in vitamin D metabolism genes: a Danish study. Pediatr diabetes. 2014;15(6):416–21 PubMedCrossRefGoogle Scholar
  • 97 Blanton D, Han Z, Bierschenk L, et al. Reduced serum vitamin D binding protein levels are associated with type 1 diabetes. diabetes. 2011;60:2566–70 PubMedPubMedCentralCrossRefGoogle Scholar
  • 98 Hussein AG, Mohamed RH, Alghobashy AA. Synergism of CYP2R1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Egyptian children. Cell Immunol. 2012;279(1):42–5 PubMedCrossRefGoogle Scholar
  • 99 Cooper JD, Smyth DJ, Walker NM, et al. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. diabetes. 2011;60(5):1624–31 PubMedPubMedCentralCrossRefGoogle Scholar
  • 100 Ramos-Lopez E, Brück P, Jansen T, Herwig J, Badenhoop K. CYP2R1 (vitamin D 25-hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans. diabetes Metab Res Rev. 2007;23(8):631–6 PubMedCrossRefGoogle Scholar
  • 101 Bailey R, Cooper JD, Zeitels L, et al. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. diabetes. 2007;56(10):2616–21 PubMedPubMedCentralCrossRefGoogle Scholar
  • 102 Frederiksen BN, Kroehl M, Fingerlin TE, Steck AK, Rewers M, Norris JM. Association between vitamin D metabolism gene polymorphisms and risk of islet autoimmunity and progression to type 1 diabetes: the diabetes autoimmunity study in the young (DAISY). J Clin Endocrinol Metab. 2013;98(11):E1845–51 PubMedPubMedCentralCrossRefGoogle Scholar
  • 103 Pociot F, McDermott MF. Genetics of type 1 diabetes mellitus. Genes Immun. 2002;3(5):235–49 PubMedCrossRefGoogle Scholar
  • 104 Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol. 2005;23:275–306 PubMedCrossRefGoogle Scholar
  • 105 Guery JC, Adorini L. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J Immunol. 1995;54:536–44 Google Scholar
  • 106 Yang CY, Leung PS, Adamopoulos IE, Gershwin ME. The implication of vitamin D and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol. 2013;45:217–26 PubMedCrossRefGoogle Scholar
  • 107 Overbergh L, Decallonne B, Waer M, et al. 1alpha,25-dihydroxyvitamin D3 induces an autoantigen specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). diabetes. 2009;49:1301–7 CrossRefGoogle Scholar
  • 108 Riachy R, Vandewalle B, Moerman E, et al. 1,25-Dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor. Apoptosis. 2006;11:151–9 PubMedCrossRefGoogle Scholar
  • 109 Casteels K, Waer M, Laureys J, et al. Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine. diabetes. 1998;51:1367–74 Google Scholar
  • 110 Del Pino-Montes J, Benito GE, Fernandez-Salazar MP, et al. Calcitriol improves streptozotocin-induced diabetes and recovers bone mineral density in diabetic rats. Calcif Tissue Int. 2004;75:526–32 PubMedCrossRefGoogle Scholar
  • 111 Takiishi T, Belle TV, Gysemans C, Mathieu C. Effects of vitamin D on antigen-specific and non-antigen-specific immune modulation: relevance for type 1 diabetes. Pediat diabetes. 2013;14:81–9 CrossRefGoogle Scholar
  • 112 Luong KVQ, Hoang Nguyen LT, Pham Nguyen DN. The role of vitamin D in protecting type 1 diabetes mellitus. diabetes Metab Res Rev. 2005;21:338–46 PubMedCrossRefGoogle Scholar
  • 113 Keen H, Ekoe JM. The geography of diabetes mellitus. Br Med Bull. 1984;40:359–65 PubMedGoogle Scholar
  • 114 Mathieu C, Waer M, Laureys J, et al. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia. 1994;37:552–8 PubMedCrossRefGoogle Scholar
  • 115 Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001;358(9292):1500–3 PubMedCrossRefGoogle Scholar
  • 116 Dong JY, Zhang WG, Chen JJ, Zhang ZL, Han SF, Qin LQ. Vitamin D intake and risk of type 1 diabetes: a meta-analysis of observational studies. Nutrients. 2013;5(9):3551–62 PubMedPubMedCentralCrossRefGoogle Scholar
  • 117 Mutlu A, Mutlu GY, Ozsu E, Cizmecioglu FM, Hatun S. Vitamin D deficiency in children and adolescents with type 1 diabetes. J Clin Res Pediatr Endocrinol. 2011;3:179–83 PubMedPubMedCentralGoogle Scholar
  • 118 Shen L, Zhuang QS, Ji HF. Assessment of vitamin D levels in type 1 and type 2 diabetes patients: Results from metaanalysis. Mol Nutr Food Res. 2016;60(5):1059–67 PubMedCrossRefGoogle Scholar
  • 119 Rasoul MA, Al-Mahdi M, Al-Kandari H, Dhaunsi GS, Haider MZ. Low serum vitamin-D status is associated with high prevalence and early onset of type-1 diabetes mellitus in Kuwaiti children. BMC Pediatr. 2016;16(1):95 PubMedPubMedCentralCrossRefGoogle Scholar
  • 120 Raab J, Giannopoulou EZ, Schneider S, et al. Prevalence of vitamin D deficiency in pre-type 1 diabetes and its association with disease progression. Diabetologia. 2014;57(5):902–8 PubMedCrossRefGoogle Scholar
  • 121 Al-Daghri NM, Al-Attas OS, Alokail MS, et al. Lower vitamin D status is more common among Saudi adults with diabetes mellitus type 1 than in non-diabetics. BMC Public Health. 2014;14:153 PubMedPubMedCentralCrossRefGoogle Scholar
  • 122 Abd-Allah SH, Pasha HF, Hagrass HA, Alghobashy AA. Vitamin D status and vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Egyptian children. Gene. 2014;536(2):430–4 PubMedCrossRefGoogle Scholar
  • 123 Greer RM, Portelli SL, Hung BS, et al. Serum vitamin D levels are lower in Australian children and adolescents with type 1 diabetes than in children without diabetes. Pediatr diabetes. 2013;14(1):31–41 PubMedCrossRefGoogle Scholar
  • 124 Thorsen SU, Mortensen HB, Carstensen B, et al. No difference in vitamin D levels between children newly diagnosed with type 1 diabetes and their healthy siblings: a 13-year nationwide Danish study. diabetes Care. 2013;36(9):e157–8 PubMedPubMedCentralCrossRefGoogle Scholar
  • 125 Sørensen IM, Joner G, Jenum PA, Eskild A, Torjesen PA, Stene LC. Maternal serum levels of 25-hydroxy-vitamin D during pregnancy and risk of type 1 diabetes in the offspring. diabetes. 2012;61(1):175–8 PubMedCrossRefGoogle Scholar
  • 126 Sørensen IM, Joner G, Jenum PA, et al. Vitamin D-binding protein and 25-hydroxyvitamin D during pregnancy in mothers whose children later developed type 1 diabetes. diabetes Metab Res Rev. 2016. doi:10.1002/dmrr.2812 Google Scholar
     Download the PDF from Vitamin D Life 2X more likely if DBP was low in 3rd trimester
  • 127 Miettinen ME, Reinert L, Kinnunen L, et al. Serum 25-hydroxyvitamin D level during early pregnancy and type 1 diabetes risk in the offspring. Diabetologia. 2012;55(5):1291–4 PubMedCrossRefGoogle Scholar
  • 128 Jia-Yi D, Weiguo Z, Jiong Jack C, Zeng-Li Z, Shu-Fen H, Li-Qiang Q. Vitamin D Intake and Risk of Type 1 diabetes: A Meta-Analysis of Observational Studies. Nutrients. 2013;5:3551–62 CrossRefGoogle Scholar
  • 129 The EURODIAB Substudy 2 Study Group. Vitamin D supplement in early childhood and risk fortype I (insulin-dependent) diabetes mellitus. Diabetologia. 1999;42:51–4 CrossRefGoogle Scholar
  • 130 Stene LC, Ulriksen J, Magnus P, Joner G. Use of cod liver oil during pregnancy associated with lower risk of type I diabetes in the offspring. Diabetologia. 2000;43:1093–8 PubMedCrossRefGoogle Scholar
  • 131 Stene LC, Joner G. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: A large, population-based, case–control study. Am J Clin Nutr. 2003;78:1128–34 PubMedGoogle Scholar
  • 132 Visalli N, Sebastiani L, Adorisio E, et al. IMDIAB Group. Environmental risk factors for type 1 diabetes in Rome and province. Arch. Dis. Child. 2003;88:695–8 Google Scholar
  • 133 Tenconi MT, Devoti G, Comelli M, et al. Pavia T1DM Registry Group. Major childhood infectious diseases and other determinants associated with type 1 diabetes: A case–control study. Acta Diabetol. 2007;44:14–9 PubMedCrossRefGoogle Scholar
  • 134 Ahadi M, Tabatabaeiyan M, Moazzami K. Association between environmental factors and risk of type 1 diabetes—A case–control study. Endokrynol Pol. 2011;62:134–7 PubMedGoogle Scholar
  • 135 Simpson M, Brady H, Yin X, et al. No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: The diabetes Autoimmunity Study in the Young (DAISY). Diabetologia. 2011;54:2779–88 PubMedPubMedCentralCrossRefGoogle Scholar
  • 136 Marjamaki L, Niinisto S, Kenward MG, et al. Maternal intake of vitamin D during pregnancy and risk of advanced ß cell autoimmunity and type 1 diabetes in offspring. Diabetologia. 2010;53:1599–607 PubMedCrossRefGoogle Scholar
  • 137 Al Sawah S, Compher CW, Hanlon AL, Lipman TH. 25-Hydroxyvitamin D and glycemic control: A cross-sectional study of children and adolescents with type 1 diabetes. diabetes Res Clin Pract. 2016;115:54–9 PubMedCrossRefGoogle Scholar
  • 138 Lamichhane AP, Crandell JL, Jaacks LM, Couch SC, Lawrence JM, Mayer-Davis EJ. Longitudinal associations of nutritional factors with glycated hemoglobin in youth with type 1 diabetes: the SEARCH Nutrition Ancillary Study. Am J Clin Nutr. 2015;101(6):1278–85 PubMedPubMedCentralCrossRefGoogle Scholar
  • 139 Aljabri KS, Bokhari SA, Khan MJ. Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiency. Ann Saudi Med. 2010;30(6):454–8 PubMedPubMedCentralCrossRefGoogle Scholar
  • 140 Mohammadian S, Fatahi N, Zaeri H, Vakili MA. Effect of Vitamin D3 Supplement in Glycemic Control of Pediatrics with Type 1 diabetes Mellitus and Vitamin D Deficiency. J Clin Diagn Res. 2015;9(3):SC05–7 PubMedPubMedCentralGoogle Scholar
  • 141 Shih EM, Mittelman S, Pitukcheewanont P, Azen CG, Monzavi R. Effects of vitamin d repletion on glycemic control and inflammatory cytokines in adolescents with type 1 diabetes. Pediat diabetes. 2016;17:36–43 CrossRefGoogle Scholar
  • 142 Nwosu BU, Maranda L. The effects of vitamin D supplementation on hepatic dysfunction, vitamin D status, and glycemic control in children and adolescents with vitamin D deficiency and either type 1 or type 2 diabetes mellitus. PLoS One. 2014;9(6), e99646 PubMedPubMedCentralCrossRefGoogle Scholar
  • 143 Herrmann M, Sullivan DR, Veillard AS, et al. The FIELD Study Investigators. Serum 25-Hydroxyvitamin D: A Predictor of Macrovascular and Microvascular Complications in Patients With Type 2 diabetes. diabetes Care. 2015;38:521–8 PubMedCrossRefGoogle Scholar
  • 144 Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med. 2002;346:1145–51 PubMedCrossRefGoogle Scholar
  • 145 Deng X, Cheng J, Shen M. Vitamin D improves diabetic nephropathy in rats by inhibiting renin and relieving oxidative stress. J Endocrinol Invest. 2016;39(6):657–66 PubMedCrossRefGoogle Scholar
  • 146 Izquierdo MJ, Cavia M, Mu?iz P, et al. Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients. BMC Nephrol. 2012;13:159 PubMedPubMedCentralCrossRefGoogle Scholar
  • 147 Li YC. Podocytes as target of vitamin D. Curr diabetes Rev. 2011;7:35–40 PubMedCrossRefGoogle Scholar
  • 148 Yuan W, Pan W, Kong J, et al. 1,25-Dihydroxyvitamin D3 Suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem. 2007;282:29821–30 PubMedCrossRefGoogle Scholar
  • 149 Parving HH, Lehnert H, Brfchner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345:870–8 PubMedCrossRefGoogle Scholar
  • 150 Agarwal R, Acharya M, Tian J, et al. Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int. 2005;68:2823–8 PubMedCrossRefGoogle Scholar
  • 151 Alborzi P, Patel NA, Peterson C, et al. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension. 2008;52:249–55 PubMedCrossRefGoogle Scholar
  • 152 de Boer IH, Sachs MC, Cleary PA, et al. diabetes Control and Complication Trial/Epidemiology of diabetes Interventions and Complications Study Research Group. Circulating vitamin D metabolites and kidney disease in type 1 diabetes. J Clin Endocrinol Metab. 2012;97(12):4780–8 PubMedPubMedCentralCrossRefGoogle Scholar
  • 153 Joergensen C, Tarnow L, Goetze JP. Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial. Diabet Med. 2015;32(3):374–81 PubMedCrossRefGoogle Scholar
  • 154 de Zeeuw D, Agarwal R, Amdahl M, et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet. 2010;376:1543–51 PubMedCrossRefGoogle Scholar
  • 155 Derakhshanian H, Shab-Bidar S, Speakman JR, Nadimi H, Djafarian K. Vitamin D and diabetic nephropathy: a systematic review and meta-analysis. Nutrition. 2015;31:1189–94 PubMedCrossRefGoogle Scholar
  • 156 National Institute of diabetes and Digestive Kidney Diseases, National Institutes of Health. diabetic neuropathies: the nerve damage of diabetes Bethesda. National Institutes of Health, The U.S. Department of Health and Human Services; 2009, Available from: hhttp://diabetes.niddk.nih.gov/dm/pubs/neuropathies/index.aspxi [updated June 25, 2012] 157 Tesfaye S, Boulton AJ, Dyck PJ, et al. diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. diabetes Care. 2010;33(10):2285–93 PubMedPubMedCentralCrossRefGoogle Scholar
  • 158 Esyeghamati A, Fotouhi A, Faghihi-Kashani S, et al. Non-linear contribution of serum vitamin D to symptomatic diabetic neuropathy: A case–control study. diabetes Res Clin Pract. 2016;111:44–50 CrossRefGoogle Scholar
  • 159 Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29:21–30 PubMedCrossRefGoogle Scholar
  • 160 Naveilhan P, Neveu I, Wion D, Brachet P. 1,25- Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. NeuroReport. 1996;7(13):2171–5. v1996 PubMedCrossRefGoogle Scholar
  • 161 Ahmadieh H, Azar ST, Lakkis N, Arabi A. Hypovitaminosis d in patients with type 2 diabetes mellitus: a relation to disease control and complications. ISRN Endocrinol. 2013;2013:641098 PubMedPubMedCentralGoogle Scholar
  • 162 Shehab D, Al-Jarallah K, Mojiminiyi OA, Al Mohamedy H, Abdella NA. Does Vitamin D deficiency play a role in peripheral neuropathy in Type 2 diabetes? Diabet Med. 2012;29:43–9 PubMedCrossRefGoogle Scholar
  • 163 Soderstrom LH, Johnson SP, Diaz VA, Mainous 3rd AG. Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001–2004 NHANES. Diabet Med. 2012;29:50–5 PubMedPubMedCentralCrossRefGoogle Scholar
  • 164 Shehab D, Al-Jarallah K, Abdella N, Mojiminiyi OA, Al Mohamedy H. Prospective evaluation of the effect of short-term oral vitamin d supplementation on peripheral neuropathy in type 2 diabetes mellitus. Med Princ Pract. 2015;24:250–6 PubMedCrossRefGoogle Scholar
  • 165 Lee P, Chen R. Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch Intern Med. 2008;168(7):171–2 CrossRefGoogle Scholar
  • 166 Van Belle TL, Gysemans C, Mathieu C. Vitamin D and diabetes: the odd couple. Trends Endocrinol Metab. 2013;24:561–8 PubMedCrossRefGoogle Scholar
  • 167 Verrotti A, Loiacono G, Mohn A, Chiarelli F. New insights in diabetic autonomic neuropathy in children and adolescents. Eur J Endocrinol. 2009;161:811–8 PubMedCrossRefGoogle Scholar
  • 168 Lv WS, Zhao WJ, Gong SL, et al. Serum 25-hydroxyvitamin D levels and peripheral neuropathy in patients with type 2 diabetes: a systematic review and meta-analysis. J Endocrinol Invest. 2015;38(5):513–8 PubMedCrossRefGoogle Scholar
  • 169 Bell DS. Reversal of the Symptoms of diabetic Neuropathy through Correction of Vitamin D Deficiency in a Type 1 diabetic Patient. Case Rep Endocrinol. 2012;2012:165056 PubMedPubMedCentralGoogle Scholar
  • 170 Yau JW, Rogers SL, Kawasaki R, et al. Meta-analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors ofdiabetic retinopathy. diabetes Care. 2012;35(3):556–64 PubMedPubMedCentralCrossRefGoogle Scholar
  • 171 Bonakdaran S, Shoeibi N. Is there any correlation between vitamin D insufficiency and diabetic retinopathy? Int J Ophthalmol. 2015;8(2):326–31 PubMedPubMedCentralGoogle Scholar
  • 172 Albert DM, Scheef EA, Wang S, et al. Calcitriol is a potent inhibitor of retinal neovascularization. Invest Ophthalmol Vis Sci. 2007;48:2327–34 PubMedCrossRefGoogle Scholar
  • 173 Ren Z, Li W, Zhao Q, Ma L, Zhu J. The impact of 1,25- dihydroxy vitamin D3 on the expressions of vascular endothelial growth factor and transforming growth factor-b1 in the retinas of rats with diabetes. diabetes Res Clin Pract. 2012;98:474–80 PubMedCrossRefGoogle Scholar
  • 174 Shokravi MT, Marcus DM, Alroy J, Egan K, Saornil MA, Albert DM. Vitamin D inhibits angiogenesis in transgenic murineretinoblastoma. Invest Ophthalmol Vis Sci. 1995;36:83–7 PubMedGoogle Scholar
  • 175 Kaur H, Donaghue KC, Chan AK, et al. Vitamin D deficiency is associated with retinopathy in children and adolescents with type 1 diabetes. diabetes Care. 2011;34(6):1400–2 PubMedPubMedCentralCrossRefGoogle Scholar
  • 176 Shimo N, Yasuda T, Kaneto H, et al. Vitamin D deficiency is significantly associated with retinopathy in young Japanese type 1 diabetic patients. diabetes Res Clin Pract. 2014;106(2):e41–3 PubMedCrossRefGoogle Scholar
  • 177 Alcubierre N, Valls J, Rubinat E, et al. Vitamin D Deficiency Is Associated with the Presence and Severity of diabetic Retinopathy in Type 2 diabetes Mellitus. J diabetes Res. 2015;2015:374178 PubMedPubMedCentralCrossRefGoogle Scholar
  • 178 Alam U, Amjad Y, Chan AW, Asghar O, Petropoulos IN, Malik RA. Vitamin D Deficiency Is Not Associated with diabetic Retinopathy or Maculopathy. J diabetes Res. 2016;2016:6156217 PubMedPubMedCentralCrossRefGoogle Scholar
  • 179 Taverna MJ, Selam JL, Slama G. Association between a protein polymorphism in the start codon of the vitamin D receptor gene and severe diabetic retinopathy in C-peptide- negative type 1 diabetes. J Clin Endocrinol Metab. 2005;90:4803–8 PubMedCrossRefGoogle Scholar
  • 180 Taverna MJ, Sola A, Guyot-Argenton C, et al. Taq I polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy. Diabetologia. 2002;45:436–42 PubMedCrossRefGoogle Scholar
  • 181 Reddy GB, Sivaprasad M, Shalini T, et al. Plasma vitamin D status in patients with type 2 diabetes with and without retinopathy. Nutrition. 2015;31(7–8):959–63 PubMedCrossRefGoogle Scholar
  • 182 Zoppini G, Galletti A, Targher G, et al. Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes. BMJ Open diabetes Res Care. 2015;3(1), e000058 PubMedPubMedCentralCrossRefGoogle Scholar
  • 183 He R, Shen J, Liu F, et al. Vitamin D deficiency increases the risk of retinopathy in Chinese patients with type 2 diabetes. Diabet Med. 2014;31(12):1657–64 PubMedCrossRefGoogle Scholar
  • 184 Patrick PA, Visintainer PF, Shi Q, Weiss IA, Brand DA. Vitamin D and retinopathy in adults with diabetes mellitus. Arch Ophthalmol. 2012;130(6):756–60 PubMedCrossRefGoogle Scholar
  • 185 Aksoy H, Akc?ay F, Kurtul N, Baykal O, Avci B. Serum 1,25 dihydroxy vitamin D (1,25(OH)2D3), 25 hydroxy vitamin D(25(OH)D) and parathormone levels in diabetic retinopathy. Clin Biochem. 2000;33(1):47–51 PubMedCrossRefGoogle Scholar
  • 186 Suzuki A, Kotake M, Ono Y, et al. Hypovitaminosis D in type 2 diabetesmellitus: associationwith microvascular complications and type of treatment. Endocr J. 2006;53(4):503–10 PubMedCrossRefGoogle Scholar
  • 187 Payne JF, Ray R, Watson DG, et al. Vitamin D insufficiency in diabetic retinopathy. Endocr Pract. 2012;18(2):185–93 PubMedPubMedCentralCrossRefGoogle Scholar
  • 188 Zhong X, Du Y, Lei Y, Liu N, Guo Y, Pan T. Effects of vitamin D receptor gene polymorphism and clinical characteristics on risk of diabetic retinopathy in Han Chinese type 2 diabetes patients. Gene. 2015;566(2):212–6 PubMedCrossRefGoogle Scholar
  • 189 Hong YJ, Kang ES, Ji MJ, et al. Association between Bsm1 Polymorphism in Vitamin D Receptor Gene and diabetic Retinopathy of Type 2 diabetes in Korean Population. Endocrinol Metab (Seoul). 2015;30(4):469–74 CrossRefGoogle Scholar
  • 190 Cyganek K, Mirkiewicz-Sieradzka B, Malecki MT, et al. Clinical risk factors and the role of VDR gene polymorphisms in diabetic retinopathy in Polish type 2 diabetes patients. Acta Diabetol. 2006;43:114–9 PubMedCrossRefGoogle Scholar
  • 191 Hao Y, Ma X, Luo Y, et al. Additional role of serum 25- hydroxyvitamin D3 levels in atherosclerosis in Chinese middleaged and elderly men. Clin Exp Pharmacol Physiol. 2014;41(3):174–9 PubMedCrossRefGoogle Scholar
  • 192 Papandreou D, Hamid ZT. The Role of Vitamin D in diabetes and Cardiovascular Disease: An Updated Review of the Literature. Dis Markers. 2015;2015:580474 PubMedPubMedCentralCrossRefGoogle Scholar
  • 193 Heidari B, Nargesi AA, Hafezi-Nejad N, et al. Assessment of serum 25 hydroxy vitamin D improves coronary heart disease risk stratification in patients withtype 2 diabetes. Am Heart J. 2015;170(3):573–9.e5 PubMedCrossRefGoogle Scholar
  • 194 Kunadian V, Ford GA, Bawamia B, et al. Vitamin D deficiency and coronary artery disease: a review of the evidence. Am Heart J. 2014;167(3):283–91 PubMedCrossRefGoogle Scholar
  • 195 Lee JH, Gadi R, Spertus JA, et al. Prevalence of vitamin D deficiency in patients with acute myocardial infarction. Am J Cardiol. 2011;107(11):1636–8 PubMedPubMedCentralCrossRefGoogle Scholar
  • 196 Schneider L, Lutsey PL, Selvin E, et al. Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study. Eur J Neurol. 2015;22(8):1220–7 PubMedPubMedCentralCrossRefGoogle Scholar
  • 197 Kendrick J, Targher G, Smits G, Chonchol M. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis. 2009;205:255–60 PubMedCrossRefGoogle Scholar
  • 198 Giovannucci E, Liu Y, Hollis BW. RimmEB. 25- hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168:1174–80 PubMedPubMedCentralCrossRefGoogle Scholar
  • 199 Hsia J, Heiss G, Ren H, et al. Women’s Health Initiative Investigators. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007;115:846–54 PubMedCrossRefGoogle Scholar
  • 200 Avenell A, MacLennan GS, Jenkinson DJ, et al. RECORD Trial Group. Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium(RECORD trial). J Clin Endocrinol Metab. 2012;97:614–22 PubMedCrossRefGoogle Scholar
  • 201 Zagami RM, Di Pino A, Urbano F, Piro S, Purrello F, Rabuazzo AM. Low circulating vitamin D levels are associated with increased arterial stiffness in prediabetic subjects identified according to HbA1c. Atherosclerosis. 2015;243(2):395–401 PubMedCrossRefGoogle Scholar
  • 202 Lee JI, Oh SJ, Ha WC, et al. Serum 25-hydroxyvitamin D concentration and arterial stiffness among type 2 diabetes. diabetes Res Clin Pract. 2012;95:42–7 PubMedCrossRefGoogle Scholar
  • 203 Lieberman R, Wadwa RP, Nguyen N, et al. The association between vitamin D and vascular stiffness in adolescents with and without type 1 diabetes. PloS ONE. 2013;8, e77272 PubMedPubMedCentralCrossRefGoogle Scholar
  • 204 van Schooten FJ, Hirvonen A, Maas LM, et al. Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking and aromatic DNA adduct levels in human right atrial tissue. FASEB J. 1998;12:1409–17 PubMedGoogle Scholar
  • 205 Ortlepp JR, von Korff A, Hanrath P, et al. Vitamin D receptor gene polymorphism Bsml is not associated with the prevalence and severity of CAD in a large-scale angiographic cohort of 3441 patients. Eur J Clin Invest. 2003;33:106–9 PubMedCrossRefGoogle Scholar
  • 206 Shanker J, Maitra A, Arvind P, et al. Role of vitamin D levels and vitamin D receptor polymorphisms in relation to coronary artery disease: the Indian atherosclerosis research study. Coron Art Disease. 2011;22:324–32 CrossRefGoogle Scholar
  • 207 Pan XM, Li DR, Yang L, et al. No association between vitamin D receptor polymorphisms and coronary artery disease in a Chinese population. DNA Cell Biol. 2009;28:521–5 PubMedCrossRefGoogle Scholar
  • 208 Maia J, da Silva AS, do Camo RF, et al. The association between vitamin D receptor gene polymorphisms (Taq1 and FokI), type 2 diabetes and micro-macrovascular complications in postmenopausal women. Appl Clin Genet. 2016;9:131–6 PubMedPubMedCentralCrossRefGoogle Scholar
  • 209 Engelen L, Schalkwijk CG, Eussen SJ, et al. Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study. Cardiovasc Diabetol. 2015;14:67 PubMedPubMedCentralCrossRefGoogle Scholar
  • 210 Sugden JA, Davies JI, Witham MD, et al. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med. 2008;25(3):320–5 PubMedCrossRefGoogle Scholar
  • 211 Joergensen C, Reinhard H, Schmedes A, et al. Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate. diabetes Care. 2012;35(1):168–72 PubMedCrossRefGoogle Scholar
  • 212 Muscogiuri G, Altieri B, Annweiler C, et al. Vitamin D and chronic diseases: the current state of the art. Arch Toxicol. 2016;18 [Epub ahead of print] Copyright information

Attached files

ID Name Comment Uploaded Size Downloads
8489 whose children later developed type 1 diabetes - 2016.pdf PDF 2016 admin 28 Sep, 2017 14:50 231.64 Kb 216
See any problem with this page? Report it (FINALLY WORKS)